Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRoivant Sciences Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.29 | -$0.25 | -$0.26 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q4 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2026 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2026 | 3 | -$0.32 | -$0.32 | -$0.32 |
| Q3 2026 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q4 2026 | 3 | -$0.33 | -$0.33 | -$0.33 |
| Q5 2026 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q6 2026 | 3 | -$0.31 | -$0.31 | -$0.31 |
| Q7 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2027 | 3 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2027 | 1 | -$0.32 | -$0.32 | -$0.32 |
Roivant Sciences Ltd. Earnings Date And Information
Roivant Sciences Ltd. last posted its earnings results on Monday, February 10th, 2025. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.24 by $0.11. The company had revenue of 9.02 M for the quarter and had revenue of 124.80 M for the year. Roivant Sciences Ltd. has generated $6 earnings per share over the last year ($5.23 diluted earnings per share) and currently has a price-to-earnings ratio of -59.93. Roivant Sciences Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 28th, 2025 based on prior year's report dates.
Roivant Sciences Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/10/2025 | Q3 2024 | -$0.24 | $0.23 | 0.47 | $5.00 M | $9.02 M |
| 09/29/2024 | Q2 2024 | N/A | -$0.31 | N/A | $45.92 M | $4.48 M |
| 08/09/2024 | Q1 2024 | N/A | $0.13 | N/A | $30.72 M | $55.13 M |
| 05/30/2024 | Q4 2023 | -$0.26 | -$0.19 | 0.08 | $31.01 M | $28.93 M |
| 02/13/2024 | Q3 2023 | -$0.27 | $6.37 | 6.64 | $31.77 M | $37.14 M |
| 11/13/2023 | Q2 2023 | -$0.28 | -$0.40 | -0.12 | $27.11 M | $37.10 M |
| 08/14/2023 | Q1 2023 | -$0.26 | -$0.38 | -0.12 | $24.49 M | $21.62 M |
| 06/28/2023 | Q4 2022 | -$0.41 | -$0.05 | 0.36 | $18.17 M | $27.38 M |
| 02/13/2023 | Q3 2022 | -$0.36 | -$0.49 | -0.13 | $14.78 M | $17.05 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Roivant Sciences Ltd. Earnings: FAQ's
Roivant Sciences Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 28th, 2025 based offlast year's report dates.
In the previous quarter, Roivant Sciences Ltd. (:ROIV) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.24 by $0.11.
The conference call for Roivant Sciences Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Roivant Sciences Ltd.'s latest earnings report can be read online.
Roivant Sciences Ltd. (:ROIV) has a recorded annual revenue of $124.80 M.
Roivant Sciences Ltd. (:ROIV) has a recorded net income of $4.35 B.Roivant Sciences Ltd. has generated $5.55 earnings per share over the last four quarters.
Roivant Sciences Ltd. (:ROIV) has a price-to-earnings ratio of -59.93 and price/earnings-to-growth ratio is 0.59.